Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer

  Free Subscription


05.07.2021

1 Acta Biochim Biophys Sin (Shanghai)
1 Arch Gynecol Obstet
5 Asian Pac J Cancer Prev
2 Aust N Z J Obstet Gynaecol
1 Biochem Genet
1 Biosci Biotechnol Biochem
1 BMC Cancer
1 BMC Public Health
2 BMC Womens Health
1 BMJ Open
1 Cancer Biol Ther
1 Cancer Cell Int
1 Cancer Control
1 Cancer Genomics Proteomics
1 Cancer Manag Res
1 Cancers (Basel)
1 Chirurgia (Bucur)
1 Clin Cancer Res
1 Clin Transl Med
1 Comput Biol Med
1 Data Brief
1 Drug Dev Res
1 EPMA J
1 Eur J Cancer Prev
1 Eur J Obstet Gynecol Reprod Biol
1 Front Mol Biosci
2 Front Oncol
1 Gynecol Obstet Invest
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Health Care Women Int
1 IEEE J Biomed Health Inform
1 IEEE Trans Med Imaging
3 In Vivo
3 Int J Gynaecol Obstet
1 Int J Health Geogr
2 Int J Mol Sci
1 Int J Radiat Oncol Biol Phys
2 J Clin Lab Anal
1 J Exp Clin Cancer Res
1 J Gynecol Obstet Hum Reprod
1 J Obstet Gynaecol
1 J Public Health (Oxf)
1 J Transl Med
1 JAMA Netw Open
1 JAMA Oncol
1 JCO Glob Oncol
1 Jpn J Infect Dis
1 Lancet Oncol
1 Med Care
1 Membranes (Basel)
1 Molecules
1 Nat Commun
1 Nurs Res
1 Oncoimmunology
1 Pan Afr Med J
1 PeerJ
2 Photodiagnosis Photodyn Ther
1 PLoS One
1 Polymers (Basel)
7 Prev Med
1 Radiat Oncol
1 Rep Pract Oncol Radiother
1 Stat Med
2 Vaccine
4 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Biochim Biophys Sin (Shanghai)

  1. HOU Y, Fan Y, Xia X, Pan J, et al
    USP31 acetylation at Lys1264 is essential for its activity and cervical cancer cell growth.
    Acta Biochim Biophys Sin (Shanghai). 2021 Jun 29. pii: 6311107.
    PubMed         Abstract available


    Arch Gynecol Obstet

  2. XIAO L, Zhu H, Shu J, Gong D, et al
    Overexpression of TGF-beta1 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration.
    Arch Gynecol Obstet. 2021 Jul 1. pii: 10.1007/s00404-021-06137.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  3. MENEUR C, Eswaran S, Adiga D, S S, et al
    Analysis of Nuclear Encoded Mitochondrial Gene Networks in Cervical Cancer.
    Asian Pac J Cancer Prev. 2021;22:1799-1811.
    PubMed         Abstract available

  4. OSEI EA, Ninon AP, Gaogli JE, Boadi EO, et al
    "I Just Went for the Screening, But I Did Not Go for the Results". Utilization of Cervical Cancer Screening and Vaccination among Females at Oyibi Community.
    Asian Pac J Cancer Prev. 2021;22:1789-1797.
    PubMed         Abstract available

  5. M R, Jose SP, Im K, S S, et al
    Curcumin-Galactomannoside Complex inhibits the Proliferation of Human Cervical Cancer Cells: Possible Role in Cell Cycle Arrest and Apoptosis.
    Asian Pac J Cancer Prev. 2021;22:1713-1720.
    PubMed         Abstract available

  6. HAMASHIMA C, Sasaki S, Hosono S, Hoshi K, et al
    National Data Analysis and Systematic Review for Human Resources for Cervical Cancer Screening in Japan.
    Asian Pac J Cancer Prev. 2021;22:1695-1702.
    PubMed         Abstract available

  7. ARAB M, Noei Teymoordash S, Talayeh M, Ghavami B, et al
    Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study.
    Asian Pac J Cancer Prev. 2021;22:1667-1670.
    PubMed         Abstract available


    Aust N Z J Obstet Gynaecol

  8. SCHECK SM, Liddle C, Wood Z, Lockett B, et al
    Five-year follow-up after cervical cytology and histology discordance: A retrospective cohort study.
    Aust N Z J Obstet Gynaecol. 2021;61:424-429.
    PubMed         Abstract available

  9. OBERMAIR HM, Bennett KF, Brotherton JML, Smith MA, et al
    Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists.
    Aust N Z J Obstet Gynaecol. 2021 Jan 29. doi: 10.1111/ajo.13310.
    PubMed         Abstract available


    Biochem Genet

  10. YANG Y, Liu Y, Liu W, Li C, et al
    miR-122 Inhibits the Cervical Cancer Development by Targeting the Oncogene RAD21.
    Biochem Genet. 2021 Jun 30. pii: 10.1007/s10528-021-10098.
    PubMed         Abstract available


    Biosci Biotechnol Biochem

  11. OHNO O, Sato K, Honma R, Chiba R, et al
    Antiapoptotic activity of methyl (3R,4E,6Z,15E)-3-hydroxyoctadecatrienoate in human cervical carcinoma HeLa cells.
    Biosci Biotechnol Biochem. 2021;85:228-232.
    PubMed         Abstract available


    BMC Cancer

  12. WU B, Xi S
    Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    BMC Cancer. 2021;21:733.
    PubMed         Abstract available


    BMC Public Health

  13. QURESHI SA, Igland J, Moen K, Gele A, et al
    Effect of a community-based intervention to increase participation in cervical cancer screening among Pakistani and Somali women in Norway.
    BMC Public Health. 2021;21:1271.
    PubMed         Abstract available


    BMC Womens Health

  14. MENSAH K, Kabore C, Zeba S, Bouchon M, et al
    Implementation of HPV-based screening in Burkina Faso: lessons learned from the PARACAO hybrid-effectiveness study.
    BMC Womens Health. 2021;21:251.
    PubMed         Abstract available

  15. ZHANG B, Hong S, Zhang G, Rong F, et al
    Clinical application of the 2011 IFCPC colposcope terminology.
    BMC Womens Health. 2021;21:257.
    PubMed         Abstract available


    BMJ Open

  16. SETHI S, Poirier B, Canfell K, Smith M, et al
    Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review.
    BMJ Open. 2021;11:e050113.
    PubMed         Abstract available


    Cancer Biol Ther


  17. Statement of Retraction: DGUOK-AS1 promotes the proliferation cervical cancer through regulating miR-653-5p/EMSY.
    Cancer Biol Ther. 2021 Jun 29:1. doi: 10.1080/15384047.2021.1926124.
    PubMed        


    Cancer Cell Int

  18. BHAT A, Yadav J, Thakur K, Aggarwal N, et al
    Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components.
    Cancer Cell Int. 2021;21:319.
    PubMed         Abstract available


    Cancer Control

  19. MBOINEKI JF, Wang P, Chen C
    Fundamental Elements in Training Patient Navigators and Their Involvement in Promoting Public Cervical Cancer Screening Knowledge and Practices: A Systematic Review.
    Cancer Control. 2021;28:10732748211026670.
    PubMed         Abstract available


    Cancer Genomics Proteomics

  20. ROWINSKI E, Magne N, Bouleftour W, Moreno-Acosta P, et al
    Genetic Analysis in Anal and Cervical Cancer: Exploratory Findings About Radioresistance in the ProfiLER Database.
    Cancer Genomics Proteomics. 2021;18:515-520.
    PubMed         Abstract available


    Cancer Manag Res

  21. CAO S, Li H, Li L
    LncRNA SNHG17 Contributes to the Progression of Cervical Cancer by Targeting microRNA-375-3p.
    Cancer Manag Res. 2021;13:4969-4978.
    PubMed         Abstract available


    Cancers (Basel)

  22. SODEIKAT P, Lia M, Martin M, Horn LC, et al
    The Importance of Clinical Examination under General Anesthesia: Improving Parametrial Assessment in Cervical Cancer Patients.
    Cancers (Basel). 2021;13.
    PubMed         Abstract available


    Chirurgia (Bucur)

  23. SAVULESCU AF, Cirlan C, Simionescu AA, Budrugeac AI, et al
    Fibrosis Associated with Retroperitoneal Abscess after Multimodal Treatment of Cervical Carcinoma - A Case Report and Brief Review of the Literature.
    Chirurgia (Bucur). 2021;116:361-367.
    PubMed         Abstract available


    Clin Cancer Res

  24. JEANNOT E, Latouche A, Bonneau C, Calmejane MA, et al
    Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer.
    Clin Cancer Res. 2021 Jul 1. pii: 1078-0432.CCR-21-0625.
    PubMed         Abstract available


    Clin Transl Med

  25. DONG S, Lu Q, Xu P, Chen L, et al
    Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening.
    Clin Transl Med. 2021;11:e457.
    PubMed        


    Comput Biol Med

  26. PENG G, Dong H, Liang T, Li L, et al
    Diagnosis of cervical precancerous lesions based on multimodal feature changes.
    Comput Biol Med. 2021;130:104209.
    PubMed         Abstract available


    Data Brief

  27. MUMBA JM, Kasonka L, Owiti OB, Andrew J, et al
    Dataset evaluating the treatment timeliness of cervical cancer in Zambia.
    Data Brief. 2021;37:107201.
    PubMed         Abstract available


    Drug Dev Res

  28. WANG Y, Shen F, Zhou J, Fang Y, et al
    Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy.
    Drug Dev Res. 2021 Jun 30. doi: 10.1002/ddr.21852.
    PubMed         Abstract available


    EPMA J

  29. KUDELA E, Liskova A, Samec M, Koklesova L, et al
    The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.
    EPMA J. 2021;12:199-220.
    PubMed         Abstract available


    Eur J Cancer Prev

  30. HAMERS FF, Poullie AI, Arbyn M
    Updated evidence-based recommendations for cervical cancer screening in France.
    Eur J Cancer Prev. 2021 Jun 28. pii: 00008469-900000000-99034.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  31. CHEUNG M, Fitzpatrick M
    The impact of the CervicalCheck controversy on provision of colposcopy services in Ireland: A cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:228-231.
    PubMed         Abstract available


    Front Mol Biosci

  32. WANG X, Zhang C, Gong M, Jiang C, et al
    A Novel Identified Long Non-coding RNA, lncRNA MEF2C-AS1, Inhibits Cervical Cancer via Regulation of miR-592/RSPO1.
    Front Mol Biosci. 2021;8:687113.
    PubMed         Abstract available


    Front Oncol

  33. CHEN X, Yu J, Zhao H, Hu Y, et al
    Laparoscopic Radical Hysterectomy Results in Higher Recurrence Rate Versus Open Abdominal Surgery for Stage IB1 Cervical Cancer Patients With Tumor Size Less Than 2 Centimeter: A Retrospective Propensity Score-Matched Study.
    Front Oncol. 2021;11:683231.
    PubMed         Abstract available

  34. HUANG C, Liang J, Lin S, Wang D, et al
    N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1.
    Front Oncol. 2021;11:666597.
    PubMed         Abstract available


    Gynecol Obstet Invest

  35. MODZELEWSKA B, Jozwik M, Kleszczewski T, Sulkowski S, et al
    Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
    Gynecol Obstet Invest. 2021;86.
    PubMed         Abstract available


    Gynecol Oncol

  36. BROOKS SE, Davis EC, Farley JH
    Disparities in pap smear screening follow up: A catalyst for collective action vs. collective despair.
    Gynecol Oncol. 2021;160:361-363.
    PubMed        


    Gynecol Oncol Rep

  37. NKURUNZIZA C, Ghebre R, Magriples U, Ntasumbumuyange D, et al
    Healthcare provider challenges to early detection of cervical cancer at primary healthcare level in Rwanda.
    Gynecol Oncol Rep. 2021;37:100810.
    PubMed         Abstract available


    Health Care Women Int

  38. LIU PL
    Linking digital health divide to HPV awareness, HPV knowledge, and cervical cancer screening among women in the United States: A trend analysis from 2008 to 2017.
    Health Care Women Int. 2021 Jul 1:1-14. doi: 10.1080/07399332.2021.1931223.
    PubMed         Abstract available


    IEEE J Biomed Health Inform

  39. R E, V S, V V, Mahanti A, et al
    Cervical Cancer Diagnostics Healthcare System Using Hybrid Object Detection Adversarial Networks.
    IEEE J Biomed Health Inform. 2021;PP.
    PubMed         Abstract available


    IEEE Trans Med Imaging

  40. MENG Z, Zhao Z, Li B, Su F, et al
    A Cervical Histopathology Dataset for Computer Aided Diagnosis of Precancerous Lesions.
    IEEE Trans Med Imaging. 2021;40:1531-1541.
    PubMed         Abstract available


    In Vivo

  41. KOH HH, Jung YY, Kim HS
    Clinicopathological Characteristics of Gastric-type Endocervical Adenocarcinoma Misdiagnosed as an Endometrial, Ovarian or Extragenital Malignancy, or Mistyped as Usual-type Endocervical Adenocarcinoma.
    In Vivo. 2021;35:2261-2273.
    PubMed         Abstract available

  42. LEE J, Park S, Woo HY, Kim HS, et al
    Clinicopathological Characteristics of Microscopic Tubal Intraepithelial Metastases from Adenocarcinoma and Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    In Vivo. 2021;35:2469-2481.
    PubMed         Abstract available

  43. SEO I, Jang H
    Aggravation of Hemorrhoids in Patients With Cervical Cancer Undergoing Radiotherapy: A Nationwide Population-based Study.
    In Vivo. 2021;35:2357-2361.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  44. MAHANDE MJ, Oneko O, Amour C, Pollie M, et al
    Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Int J Gynaecol Obstet. 2021;154:113-118.
    PubMed         Abstract available

  45. KIM MH, Jung HJ, Park SI, Kim BJ, et al
    Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13574.
    PubMed         Abstract available

  46. MWANAHAMUNTU M, Kapambwe S, Pinder LF, Matambo J, et al
    The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia.
    Int J Gynaecol Obstet. 2021 Jul 1. doi: 10.1002/ijgo.13808.
    PubMed         Abstract available


    Int J Health Geogr

  47. TAFADZWA D, Julien R, Lina B, Eliane R, et al
    Spatiotemporal modelling and mapping of cervical cancer incidence among HIV positive women in South Africa: a nationwide study.
    Int J Health Geogr. 2021;20:30.
    PubMed         Abstract available


    Int J Mol Sci

  48. UDOMWAN P, Pientong C, Tongchai P, Burassakarn A, et al
    Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available

  49. TEMIZ E, Koyuncu I, Durgun M, Caglayan M, et al
    Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  50. DYER BA, Feng CH, Eskander R, Sharabi AB, et al
    Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined with Radiation.
    Int J Radiat Oncol Biol Phys. 2020 Sep 14. pii: S0360-3016(20)34287.
    PubMed         Abstract available


    J Clin Lab Anal

  51. WANG Y, Chen A, Zheng C, Zhao L, et al
    miR-92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting PIK3R1.
    J Clin Lab Anal. 2021 Jul 3:e23893. doi: 10.1002/jcla.23893.
    PubMed         Abstract available

  52. MA J, Yang L, Feng H, Zheng L, et al
    CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    J Clin Lab Anal. 2021 Jul 1:e23793. doi: 10.1002/jcla.23793.
    PubMed         Abstract available


    J Exp Clin Cancer Res

  53. LI Q, Zhou ZW, Duan W, Qian CY, et al
    Inhibiting the redox function of APE1 suppresses cervical cancer metastasis via disengagement of ZEB1 from E-cadherin in EMT.
    J Exp Clin Cancer Res. 2021;40:220.
    PubMed         Abstract available


    J Gynecol Obstet Hum Reprod

  54. MABUCHI S, Shimura K, Matsumoto Y
    The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapy.
    J Gynecol Obstet Hum Reprod. 2021 Jun 22:102190.
    PubMed         Abstract available


    J Obstet Gynaecol

  55. HUANG L, He Y, Gong Y
    The long-term urinary dysfunction after type C2 radical hysterectomy in patients with cervical cancer.
    J Obstet Gynaecol. 2021 Jun 25:1-4. doi: 10.1080/01443615.2021.1920004.
    PubMed         Abstract available


    J Public Health (Oxf)

  56. PATERSON P, Mounier-Jack S, Saliba V, Yarwood J, et al
    Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England.
    J Public Health (Oxf). 2021;43:189-196.
    PubMed         Abstract available


    J Transl Med

  57. LI Y, Lu S, Wang S, Peng X, et al
    Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses.
    J Transl Med. 2021;19:222.
    PubMed         Abstract available


    JAMA Netw Open

  58. GRIMES DR, Corry EMA, Malagon T, O'Riain C, et al
    Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
    JAMA Netw Open. 2021;4:e2115321.
    PubMed         Abstract available


    JAMA Oncol

  59. TAKSLER GB, Peterse EFP, Willems I, Ten Haaf K, et al
    Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    JAMA Oncol. 2021;7:885-894.
    PubMed         Abstract available


    JCO Glob Oncol

  60. JOHN-AKINOLA YO, Oluwasanu MM, Oladepo O
    Urban Poor Community Settings' Knowledge and Screening Practices for Cervical Cancer in Ibadan, Nigeria.
    JCO Glob Oncol. 2021;7:1024-1031.
    PubMed         Abstract available


    Jpn J Infect Dis

  61. CALISKAN E, Coskun SK, Ozturk CE, Cangur S, et al
    Analysis of HPV Genotypes and Liquid-Based Cervical Cytology: Results from a Tertiary Academic Center in Northwestern Turkey.
    Jpn J Infect Dis. 2021;74:69-72.
    PubMed         Abstract available


    Lancet Oncol

  62. GOURD E
    COVID-19 pandemic causes cervical cancer screening crisis.
    Lancet Oncol. 2021 Jun 24. pii: S1470-2045(21)00382.
    PubMed        


    Med Care

  63. MURPHY KA, Stone EM, Presskreischer R, McGinty EE, et al
    Cancer Screening Among Adults With and Without Serious Mental Illness: A Mixed Methods Study.
    Med Care. 2021;59:327-333.
    PubMed         Abstract available


    Membranes (Basel)

  64. ACEVEDO-SANCHEZ V, Rodriguez-Hernandez RM, Aguilar-Ruiz SR, Torres-Aguilar H, et al
    Extracellular Vesicles in Cervical Cancer and HPV Infection.
    Membranes (Basel). 2021;11.
    PubMed         Abstract available


    Molecules

  65. MEDEIROS R, Horta B, Freitas-Silva J, Silva J, et al
    Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages.
    Molecules. 2021;26.
    PubMed         Abstract available


    Nat Commun

  66. ZHU X, Li X, Ong K, Zhang W, et al
    Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears.
    Nat Commun. 2021;12:3541.
    PubMed         Abstract available


    Nurs Res

  67. KUE J, Szalacha L, Rechenberg K, Nolan TS, et al
    Communication Among Southeast Asian Mothers and Daughters About Cervical Cancer Prevention.
    Nurs Res. 2021 Jun 23. pii: 00006199-900000000-99656.
    PubMed         Abstract available


    Oncoimmunology

  68. KOL A, Lubbers JM, Terwindt ALJ, Workel HH, et al
    Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer.
    Oncoimmunology. 2021;10:1936391.
    PubMed         Abstract available


    Pan Afr Med J

  69. MKHONTA SS, Shirinde J
    Registered nurses' perspectives on barriers of cervical cancer screening in Swaziland: a qualitative study.
    Pan Afr Med J. 2021;38:295.
    PubMed         Abstract available


    PeerJ

  70. ALSOUS MM, Ali A, Al-Azzam S, Karasneh R, et al
    Knowledge about cervical cancer and awareness about human papillomavirus vaccination among medical students in Jordan.
    PeerJ. 2021;9:e11611.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  71. RAN R, Wang M, Li X, Liu Q, et al
    A prospective study of photodynamic therapy for cervical squamous intraepithelial lesion.
    Photodiagnosis Photodyn Ther. 2021;34:102185.
    PubMed         Abstract available

  72. CANG W, Gu L, Hong Z, Wu A, et al
    Effectiveness of photodynamic therapy with 5-aminolevulinic acid on HPV clearance in women without cervical lesions.
    Photodiagnosis Photodyn Ther. 2021;34:102293.
    PubMed         Abstract available


    PLoS One

  73. LI Y, Kong Q, Wei H, Wang Y, et al
    Comparison of the complications between minimally invasive surgery and open surgical treatments for early-stage cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253143.
    PubMed         Abstract available


    Polymers (Basel)

  74. ALOMARI M, Almahasheer A, Jermy BR, Al-Dossary AA, et al
    Impact of Poly (Styrene-Acrylic Acid) Latex Nanoparticles on Colorectal and Cervical Cancer Cells.
    Polymers (Basel). 2021;13.
    PubMed         Abstract available


    Prev Med

  75. TSU VD, LaMontagne DS, Atuhebwe P, Bloem PN, et al
    National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.
    Prev Med. 2021;144:106335.
    PubMed         Abstract available

  76. JANS L, Zetterstrom K, Bergengren L, Helenius G, et al
    The value of adding a single co-test in HPV primary screening.
    Prev Med. 2021;149:106617.
    PubMed         Abstract available

  77. SUNDSTROM K, Herweijer E, Wang J
    Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccination.
    Prev Med. 2021;144:106382.
    PubMed         Abstract available

  78. BRUNI L, Saura-Lazaro A, Montoliu A, Brotons M, et al
    HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
    Prev Med. 2021;144:106399.
    PubMed         Abstract available

  79. BRANDT HM, Vanderpool RC, Pilar M, Zubizarreta M, et al
    A narrative review of HPV vaccination interventions in rural U.S. communities.
    Prev Med. 2021;145:106407.
    PubMed         Abstract available

  80. KUTER BJ, Garland SM, Giuliano AR, Stanley MA, et al
    Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?
    Prev Med. 2021;144:106321.
    PubMed         Abstract available

  81. WENTZENSEN N, Chirenje ZM, Prendiville W
    Treatment approaches for women with positive cervical screening results in low-and middle-income countries.
    Prev Med. 2021;144:106439.
    PubMed         Abstract available


    Radiat Oncol

  82. MILLER H, Matsuo KM, Roman LD, Yessaian AA, et al
    Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.
    Radiat Oncol. 2021;16:123.
    PubMed         Abstract available


    Rep Pract Oncol Radiother

  83. CARVAJAL F, Carvajal C, Merino T, Lopez V, et al
    Radiotherapy for cervical cancer: Chilean consensus of the Society of Radiation Oncology.
    Rep Pract Oncol Radiother. 2021;26:291-302.
    PubMed         Abstract available


    Stat Med

  84. ARON J, Albert PS, Wentzensen N, Cheung LC, et al
    Hidden mover-stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer.
    Stat Med. 2021;40:3460-3476.
    PubMed         Abstract available


    Vaccine

  85. CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
    Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
    PubMed         Abstract available

  86. UWINS C, Cyriac S, Bhandoria G
    HPV vaccine: Expanding indications and global disparity.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.
    PubMed        


    Zhonghua Yi Xue Za Zhi

  87. ZHAO FH, Ren WH
    [Accelerating the elimination of cervical cancer in China and building a paradigm for "Healthy China" cancer prevention].
    Zhonghua Yi Xue Za Zhi. 2021;101:1831-1834.
    PubMed         Abstract available

  88. REN WH, Zhao XL, Zhao FH
    [Global guidelines for cervical cancer screening: a systematic review].
    Zhonghua Yi Xue Za Zhi. 2021;101:1882-1889.
    PubMed         Abstract available

  89. ZHAO YX, Ma L, Ren WH, Song B, et al
    [Analysis of the reported data of National Cervical Cancer Screening Program in Rural Areas in China from 2009 to 2018].
    Zhonghua Yi Xue Za Zhi. 2021;101:1863-1868.
    PubMed         Abstract available

  90. ZHANG M, Bao HL, Wang LM, Zhao ZP, et al
    [Analysis of cervical cancer screening and related factors in China].
    Zhonghua Yi Xue Za Zhi. 2021;101:1869-1874.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: